This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Griffith University. Active years: 2018-2026.
Company Filing History:
Years Active: 2018-2026
Title: The Innovative Contributions of Patrice Guillon
Introduction
Patrice Guillon is a notable inventor based in Southport, Australia. She has made significant contributions to the field of antiviral agents, showcasing her expertise through her innovative patents. With a total of 2 patents, her work is focused on developing compounds that can effectively combat viral infections.
Latest Patents
Guillon's latest patents include groundbreaking inventions related to antiviral agents. The first patent describes a compound of Formula (I), or a pharmaceutically acceptable salt thereof, along with pharmaceutical compositions that comprise the compound. This invention highlights the potential uses of these compounds in treating diseases caused by viral infections. The second patent also focuses on antiviral agents, detailing compounds that exhibit an antiviral effect by modulating the activity of viral haemagglutinin and neuraminidase enzymes.
Career Highlights
Patrice Guillon is affiliated with Griffith University, where she continues her research and development in the field of antiviral agents. Her work is characterized by a commitment to advancing medical science and improving treatment options for viral infections.
Collaborations
Throughout her career, Guillon has collaborated with esteemed colleagues such as Ibrahim El-Deeb and Mark Von Itzstein. These partnerships have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Patrice Guillon's contributions to the field of antiviral agents demonstrate her dedication to innovation and research. Her patents reflect a significant advancement in the fight against viral infections, showcasing her role as a leading inventor in this critical area of science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
